$8.29
0.17[2.09%]
At close: Apr 29
$8.29
0[0.00%]
PreMarket: 8:57AM EDT
Recursion Pharmaceuticals
(NASDAQ:RXRX)Recursion Pharmaceuticals Stock (NASDAQ:RXRX), Earnings Estimates, EPS, and Revenue
Recursion Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 10
EPS Estimate
$-0.420
Quarterly Revenue Estimate
$13.1M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$43.9M
Analyze the earnings history of Recursion Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/10/2024 | PM | RXRX | Q1 | -$0.34 | -$0.42 | — | — | $12.13M | $13.08M | — | — | Get Alert |
| 02/27/2024 | PM | RXRX | Q4 | -$0.31 | -$0.45 | -$0.42 | 6.67% | $13.68M | $20.53M | $10.89M | -46.95% | Get Alert |
| 11/09/2023 | AM | RXRX | Q3 | -$0.35 | -$0.38 | -$0.43 | -13.16% | $13.16M | $12.87M | $10.53M | -18.16% | Get Alert |
| 08/08/2023 | AM | RXRX | Q2 | -$0.38 | -$0.37 | -$0.38 | -2.70% | $7.67M | $11.91M | $11.02M | -7.50% | Get Alert |
| 05/08/2023 | PM | RXRX | Q1 | -$0.33 | -$0.35 | -$0.34 | 2.86% | $5.33M | $14.44M | $12.13M | -15.97% | Get Alert |
| 02/27/2023 | PM | RXRX | Q4 | -$0.38 | -$0.29 | -$0.31 | -6.90% | $2.53M | $24.00M | $13.68M | -43.02% | Get Alert |
| 11/08/2022 | PM | RXRX | Q3 | -$0.28 | -$0.38 | -$0.35 | 7.89% | $2.53M | $6.97M | $13.16M | 88.81% | Get Alert |
| 08/09/2022 | PM | RXRX | Q2 | -$0.31 | -$0.40 | -$0.38 | 5.00% | $2.55M | $5.40M | $7.67M | 42.11% | Get Alert |
| 05/10/2022 | PM | RXRX | Q1 | -$1.33 | $0.10 | -$0.33 | -430.00% | $2.56M | $83.95M | $5.33M | -93.65% | Get Alert |
| 03/23/2022 | AM | RXRX | Q4 | -$1.17 | -$0.31 | -$0.38 | -22.58% | $2.70M | $6.07M | $2.53M | -58.27% | Get Alert |
| 11/10/2021 | AM | RXRX | Q3 | -$1.09 | -$0.28 | -$0.28 | 0.00% | $1.02M | $2.62M | $2.53M | -3.28% | Get Alert |
| 08/13/2021 | AM | RXRX | Q2 | -$0.88 | -$0.23 | -$0.31 | -34.78% | — | $2.72M | $2.55M | -6.29% | Get Alert |
| 05/12/2021 | AM | RXRX | Q1 | -$0.85 | — | -$1.33 | — | $60.00K | — | $2.56M | — | Get Alert |
FAQ
When is Recursion Pharmaceuticals (NASDAQ:RXRX) reporting earnings?
Recursion Pharmaceuticals (RXRX) is scheduled to report earnings on May 10, 2024. The last reported earnings were for reported on February 27, 2024 for Q4.
What were the latest earnings per share (EPS) for Recursion Pharmaceuticals (NASDAQ:RXRX)?
The Actual EPS was $-0.42, which beat the estimate of $-0.45.
What were Recursion Pharmaceuticals’s (NASDAQ:RXRX) revenues?
The Actual Revenue was $10.9M, which missed the estimate of $20.5M.
Browse earnings estimates, EPS, and revenue on all stocks.